Tablets, 185mg Now Available by Prescription in the United StatesBEDMINSTER, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- ...

Alembic Pharmaceuticals has received FDA approval to market a generic version of an antifungal medication, Efinaconazole ...

Alembic Pharma gets USFDA approval to market generic Efinaconazole Topical Solution (10%) for fungal infections. Market size ...

Alembic Pharmaceuticals has received USFDA approval to market its generic antifungal medication, Efinaconazole Topical Solution.

Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Efinaconazole ...

Pivya ® (pivmecillinam tablets) is now available for the treatment of female patients aged 18 years and older with uncomplicated urinary tract infections (uUTI) caused by susceptible isolates of ...

Alembic Pharmaceuticals announced that it has received final approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Efinaconazole Topical Solution, 10%.

Indian drugmaker Alembic Pharmaceuticals on Thursday reported lower third‑quarter profit on Thursday after taking a one-time charge linked to India's new ‍labour code, despite strong demand for its ...

Alembic Pharmaceuticals completed a USFDA cGMP inspection at its Karakhadi Injectable Facility (F-3) from February 9–18, 2026. The inspection ended with two observations, none related to data ...